There are 2789 resources available
1117P - Mutational landscape of large cell neuroendocrine lung carcinoma: Molecular characterization using next generation sequencing
Presenter: Maria San Roman-Gil
Session: ePoster Display
1031TiP - Vascular intervention combined with camrelizumab and apatinib for patients with inoperable solid tumors: An exploratory study
Presenter: Feng Gao
Session: ePoster Display
1107P - Durvalumab plus tremelimumab in patients with grade 3 neuroendocrine neoplasms of gastroenteropancreatic origin: Updated results from the multicenter phase II DUNE trial (GETNE 1601)
Presenter: Jaume Capdevila
Session: ePoster Display
1108P - Folfirinox in the treatment of advanced gastroenteropancreatic neuroendocrine carsinomas
Presenter: Baddar Pervaiz Butt
Session: ePoster Display
1109P - The psychological impact of COVID-19 pandemic on patients with NETs: Between resilience and vulnerability
Presenter: Eleonora Lauricella
Session: ePoster Display
1035TiP - A phase I/Ib study of MPT-0118 as monotherapy and in combination with pembrolizumab in subjects with advanced or metastatic solid tumors
Presenter: David Sommerhalder
Session: ePoster Display
Resources:
Abstract
1111P - New prognostic frontiers for lung neuroendocrine tumors: An Italian-Spanish multicentric study of 200 cases
Presenter: Anna La Salvia
Session: ePoster Display
1112P - Modified TGR: A new strong radiological marker to accurately predict early response to PRRT in GEPNETs
Presenter: Federica Scalorbi
Session: ePoster Display
1043P - NF1 mutations and immune checkpoint inhibitor outcomes in patients with BRAF wildtype melanoma
Presenter: Maysa Vilbert
Session: ePoster Display